产品说明
包装
5, 25 mg in glass bottle
生化/生理作用
Alvimopan is a gastroprokinetic peripheral mu-opioid receptor antagonist. As a drug, Alvimopan is given to patients undergoing bowel surgery to protect the bowel from the effects of opioid medications that are used to treat pain, blocking the undesirable GI side-effects of the opioid agonists without affecting analgesia or causing withdrawal. Alvimopan does not cross the blood-brain barrier, competitively binding to gastrointestinal tract mu-opioid receptors.
基本信息
经验(实验)分子式 | C25H32N2O4 |
分子量 | 424.53 |
MDL编号 | MFCD09838268 |
PubChem化学物质编号 | 329825803 |
NACRES | NA.77 |
产品性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | powder |
旋光性 | [α]/D +46 to +52°, c = 1.0 in DMSO |
颜色 | white to beige |
溶解性 | DMSO: 10 mg/mL, clear |
储存温度 | 2-8℃ |
SMILES string | C[C@H]1CN(C[C@@H](C(NCC(O)=O)=O)CC2=CC=CC=C2)CC[C@]1(C3=CC=CC(O)=C3)C |
InChI | 1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 |
InChI key | UPNUIXSCZBYVBB-JVFUWBCBSA-N |
Gene Information | human ... OPRM1(4988) |
安全信息
象形图 | |
警示用语: | Warning |
危险声明 | H315 - H319 - H400 |
预防措施声明 | P273 - P302 + P352 - P305 + P351 + P338 |
危险分类 | Aquatic Acute 1 - Eye Irrit. 2 - Skin Irrit. 2 |
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich